Cancer Conversations Blog

October 25, 2017

Don’t Put it Off: Get Screened for Breast Cancer

By: Fox Chase Conversations

Nearly every woman knows someone who’s had breast cancer—whether a loved one or a friend. More than 300,000 women in the U.S. will be diagnosed with the disease this year, and more than 40,000 will die of it.

October 18, 2017

Preparing Your Body for Chemotherapy

By: Fox Chase Conversations

Many people are apprehensive before their first chemotherapy appointment. Preconceived notions and misinformation can add to the stress.

Sharon Schwartz, Certified Nurse Practioner and Cofertility Coordinator
October 12, 2017

Fertility Preservation in Cancer Patients

By: Risk Assessment Program

Questions for Sharon Schwartz, Certified Nurse Practioner and Cofertility Coordinator at Fox Chase Cancer Center about fertility preservation in cancer patients.

October 11, 2017

Trial Helps Determine Optimal Dose of Next-Generation Drug for Acute Myeloid Leukemia

By: Fox Chase Conversations

The trial ran for two years across 14 U.S. medical centers, and sought to establish the optimal dose and treatment schedule for guadecitabine, a next-generation hypomethylating drug.

October 10, 2017

Genetic Testing May Give Answers, but May Also Leave Questions

By: Andrea Forman, MS, LCGC; Mary B. Daly, MD, PhD, FACP

It is important to understand that there are different types of genetic testing that might be offered, multiple results may arise, and sometimes limited action is available.

Galina Semenova
October 1, 2017

Trainee Spotlight: Galina Semenova

By: Fox Chase Postdoctoral Program

"Torn between art and science I wondered if I would ever be able to find a profession that would satisfy my scientific curiosity as well as my need for creative practice."

Eric M. Horwitz, MD, FASTRO
September 25, 2017

Eric M. Horwitz Honored as a Fellow at ASTRO

By: Fox Chase Today

Eric M. Horwitz, MD, chair of the Department of Radiation Oncology at Fox Chase, will be honored as a fellow of The American Society for Radiation Oncology at the organization’s 59th Annual Meeting held this week, September 24-27, 2017 in San Diego. 

Richard Fisher, MD
September 22, 2017

Dr. Fisher Reflects on the Regimen that Changed Lymphoma Treatment

By: Fox Chase Conversations

In honor of Leukemia and Lymphoma Awareness Month in September, Richard I. Fisher, President and CEO of Fox Chase Cancer Center, spoke about his seminal paper on the CHOP regimen for the treatment of advanced non-Hodgkin’s lymphoma. It was published in the New England Journal of Medicine 25 years ago this April. It marked a breakthrough in cancer care, and positioned Fisher as an international thought leader in the treatment of lymphoma.